MASLD
Clinical trials for MASLD explained in plain language.
Never miss a new study
Get alerted when new MASLD trials appear
Sign up with your email to follow new studies for MASLD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot targets dangerous liver fat
Disease control OngoingThis study is testing an investigational injection called DR10624 to see if it can reduce liver fat and scarring in people with metabolic fatty liver disease (MASLD) who are at high risk. About 110 participants will receive either the drug or a placebo for 12 weeks, with research…
Matched conditions: MASLD
Phase: PHASE2 • Sponsor: Zhejiang Doer Biologics Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Can diet beat pills for fixing a fatty liver?
Disease control ENROLLING_BY_INVITATIONThis study aims to see if a specific eating plan is better than a prescription medication for reducing liver fat and scarring. Researchers will compare a Mediterranean diet combined with intermittent fasting against the weight-loss drug naltrexone/bupropion (Mysimba®). The goal i…
Matched conditions: MASLD
Phase: PHASE4 • Sponsor: Carmen Dietvorst • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
Scientists seek blood test to replace liver biopsy for silent fatty liver disease
Knowledge-focused OngoingThis study aims to develop better, non-invasive tests to screen for, diagnose, and monitor fatty liver disease (MASLD) in people undergoing weight-loss surgery. Researchers will also look for markers in the blood that might predict if a patient's type 2 diabetes goes away after s…
Matched conditions: MASLD
Sponsor: Royal College of Surgeons in Ireland - Medical University of Bahrain • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:01 UTC